Ifosfamide with regional hyperthermia in soft-tissue sarcomas

For high-risk soft tissue sarcomas (HR-STS) of adults, new
treatment strategies are needed to improve outcome with regard to
local control and overall survival. Therefore, systemic
chemotherapy has been integrated either after (adjuvant) or before
(neoadjuvant) optimal local treatment by surgery and radiotherapy
in HR-STS. The combination with regional hyperthermia as a new
treatment strategy seems to open a new therapeutic window.
Copyright (C) 2003 S. Karger AG, Basel.